Free Review Articles on Multiple sclerosis                                 Metatextbook

Freie Reviews über Multiple Sklerose                                 Look here for Journal Homepages

  • Multiple sclerosis
  • Teriflunomide
  • Glatiramer acetate
  • Natalizumab
  • Spasticity
  • MRS (Method)
  • Dalfampridine
  • Optic neuritis
  • FTY720
  • Astrocyte
  • Liquor puncture
  • Oligoclonal band study
  • Apolipoprotein E
  • Histone deacetylase
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12006Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review.



    		+-nlBMJ 332(7546):875-84 (2006)
    22006Diagnosis and treatment of multiple sclerosis.



    		+-nlBMJ 332(7540):525-7 (2006)
    32002Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review.



    		+-nlArch Intern Med 162(19):2161-9 (2002)
    41998Multiple sclerosis: what have we learned from magnetic resonance imaging studies?



    		+-nlArch Intern Med 158(6):565-73 (1998)
    52006Multiple sclerosis: treating symptoms, and other general medical issues.



    		+-nlCleve Clin J Med 73(2):177-86 (2006)
    62006Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease.



    		+-nlCleve Clin J Med 73(1):91-102 (2006)
    72004The neuropsychiatry of multiple sclerosis.



    		+-nlCan J Psychiatry 49(3):157-63 (2004) Feinstein A
    81996Psychiatric manifestations of multiple sclerosis: a review.



    		+-nlCan J Psychiatry 41(7):441-5 (1996)
    92009Review of teriflunomide and its potential in the treatment of multiple sclerosis.



    		+-nlNeuropsychiatr Dis Treat 5(-):333-40 (2009)
    102008Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosis.



    		+-nlNeuropsychiatr Dis Treat 4(2):321-36 (2008)
    112007Glatiramer acetate in the treatment of multiple sclerosis.



    		+-nlNeuropsychiatr Dis Treat 3(2):259-67 (2007)
    122006The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.



    		+-nlNeuron 52(1):61-76 (2006)
    132003Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis.



    		+-nlNeuron 38(5):685-8 (2003)
    142007The extracellular matrix in multiple sclerosis pathology.



    		+-nlJ Neurochem 103(4):1293-301 (2007)
    152007Multiple sclerosis: a battle between destruction and repair.



    		+-nlJ Neurochem 100(2):295-306 (2007)
    162007Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.



    		+-nlDialogues Clin Neurosci 9(2):125-39 (2007)
    172007Glatiramer acetate in multiple sclerosis: a review.



    		+-nlCNS Drug Rev 13(2):178-91 (2007)
    182007Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases.



    		+-nlCNS Drug Rev 13(1):79-95 (2007)
    192003Treatments for spasticity and pain in multiple sclerosis: a systematic review.



    		+-nlHealth Technol Assess 7(40):iii, ix-x, 1-111 (2003)
    201993Epidemiologic evidence for multiple sclerosis as an infection.



    		+-nlClin Microbiol Rev 6(4):382-427 (1993)
    211999The cellular immunology of multiple sclerosis.



    		+-nlJ Leukoc Biol 65(4):444-52 (1999)
    222007The immunological basis for treatment of multiple sclerosis.



    		+-nlScand J Immunol 66(4):374-82 (2007)
    232009Complement in multiple sclerosis: its role in disease and potential as a biomarker.



    		+-nlClin Exp Immunol 155(2):128-39 (2009)
    242008Myelin repair: the role of stem and precursor cells in multiple sclerosis.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 363(1489):171-83 (2008)
    251999Therapeutic strategies in multiple sclerosis. II. Long-term repair.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1711-20 (1999)
    261999Therapeutic strategies in multiple sclerosis. I. Immunotherapy.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1697-710 (1999)
    271999Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1687-95 (1999)
    281999Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1675-86 (1999)
    291999The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1649-73 (1999)
    301999Axon damage and repair in multiple sclerosis.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1641-7 (1999)
    311999The pathology of multiple sclerosis and its evolution.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1635-40 (1999)
    321999The genetic epidemiology of multiple sclerosis.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1623-34 (1999)
    331999Multiple sclerosis: the disease and its manifestations.



    		+-nlPhilos Trans R Soc Lond B Biol Sci 354(1390):1615-22 (1999)
    342006Tumor-like multiple sclerosis: report of four cases and literature review.



    		+-nlTumori 92(6):559-62 (2006)
    352006Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies.



    		+-nlArch Neurol 63(1):25-33 (2006)
    362005Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.



    		+-nlArch Neurol 62(10):1519-30 (2005)
    372005Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.



    		+-nlArch Neurol 62(9):1345-56 (2005)
    382005Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.



    		+-nlArch Neurol 62(6):865-70 (2005)
    392005Glatiramer acetate therapy: the plot thickens.



    		+-nlArch Neurol 62(6):858-9 (2005)
    402005Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker.



    		+-nlArch Neurol 62(1):33-6 (2005)
    412002Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance.



    		+-nlBrain 125(Pt 8):1676-95 (2002)
    421998The role of magnetic resonance techniques in understanding and managing multiple sclerosis.



    		+-nlBrain 121 ( Pt 1)(-):3-24 (1998)
    431997Primary progressive multiple sclerosis.



    		+-nlBrain 120 ( Pt 6)(-):1085-96 (1997)
    442004Multiple sclerosis: etiological mechanisms and future directions.



    		+-nlExp Biol Med (Maywood) 229(1):12-20 (2004)
    452004Multiple sclerosis.



    		+-nlJ Clin Invest 113(6):788-94 (2004)
    462005Developing therapeutics for the treatment of multiple sclerosis.



    		+-nlNeuroRx 2(4):638-49 (2005)
    472005Imaging of multiple sclerosis: role in neurotherapeutics.



    		+-nlNeuroRx 2(2):277-303 (2005) Bakshi R
    482005Multiple sclerosis: diagnosis and the management of acute relapses.



    		+-nlPostgrad Med J 81(955):302-8 (2005)
    491992Multiple sclerosis: the impact of MR imaging.



    		+-nlAJR Am J Roentgenol 158(4):849-57 (1992)
    501991Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.



    		+-nlAJR Am J Roentgenol 157(5):1073-8 (1991)
    512009Tissue-specific MR imaging in multiple sclerosis.



    		+-nlAJNR Am J Neuroradiol 30(7):1277-8 (2009)
    522007Diffusion MR imaging in multiple sclerosis: technical aspects and challenges.



    		+-nlAJNR Am J Neuroradiol 28(3):411-20 (2007)
    532006Multiple sclerosis: the role of MR imaging.



    		+-nlAJNR Am J Neuroradiol 27(6):1165-76 (2006)
    542006Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.



    		+-nlAJNR Am J Neuroradiol 27(2):455-61 (2006)
    552005Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.



    		+-nlAJNR Am J Neuroradiol 26(3):572-7 (2005)
    562002Diffusion tensor MR imaging of gray matter in different multiple sclerosis phenotypes.



    		+-nlAJNR Am J Neuroradiol 23(6):899-900 (2002)
    571998Perspectives on multiple sclerosis.



    		+-nlAJNR Am J Neuroradiol 19(7):1251-65 (1998)
    581998Investigating multiple sclerosis with spectroscopic imaging: harbinger of a new paradigm.



    		+-nlAJNR Am J Neuroradiol 19(6):1002-3 (1998)
    592010MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.



    		+-nlAJNR Am J Neuroradiol 31(7):1171-7 (2010)
    602010Dirty-appearing white matter: a disregarded entity in multiple sclerosis.



    		+-nlAJNR Am J Neuroradiol 31(3):390-1 (2010)
    612010Natalizumab (Tysabri).



    		+-nlAJNR Am J Neuroradiol 31(9):1588-90 (2010)
    622010Cognitive deficits in multiple sclerosis: a systematic review.



    		+-nlArq Neuropsiquiatr 68(4):632-41 (2010)
    632011Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.



    		+-nlASN Neuro 3(4):- (2011)
    642010The role of natalizumab in the treatment of multiple sclerosis.



    		+-nlAm J Manag Care 16(6 Suppl):S164-70 (2010)
    652011Guidelines and best practices for appropriate use of dalfampridine in managed care populations.



    		+-nlAm J Manag Care 17 Suppl 5 Improving(-):S154-60 (2011)
    662010Is multiple sclerosis a mitochondrial disease?



    		+-nlBiochim Biophys Acta 1802(1):66-79 (2010)
    672009Optic neuritis and risk of MS: differential diagnosis and management.



    		+-nlCleve Clin J Med 76(3):181-90 (2009)
    682009FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.



    		+-nlBr J Pharmacol 158(5):1173-82 (2009)
    692008Astrocytes in multiple sclerosis: a product of their environment.



    		+-nlCell Mol Life Sci 65(17):2702-20 (2008)
    702008Value of oligoclonal band study in clinically isolated syndromes and multiple sclerosis.



    		+-nlExpert Rev Neurother 8(9):1279-80 (2008)
    712008Epstein-Barr virus in the development of multiple sclerosis.



    		+-nlExpert Rev Neurother 8(3):331-3 (2008)
    722007Autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.



    		+-nlAnn Acad Med Singapore 36(6):421-6 (2007)
    732010T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.



    		+-nlClin Exp Immunol 162(1):1-11 (2010)
    742010The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.



    		+-nlClin Dev Immunol 2010(-):186813 (2010)
    752009Genetics and pathogenesis of multiple sclerosis.



    		+-nlSemin Immunol 21(6):328-33 (2009)
    762011The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis.



    		+-nlMol Med 17(5-6):442-7 (2011)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.